Authors
Theodoros P Vassilakopoulos, Alexia Piperidou, Zois Mellios, Evgenia Verigou, Eirini Katodritou, Christina Kalpadakis, Sotirios G Papageorgiou, Chrysovalantou Chatzidimitriou, Vassilios Prassopoulos, Marina P Siakantaris, Hara Giatra, Dimitrios Karantanis, Nikolaos Papathanasiou, Loukia Ligdi, Anastasia Kopsaftopoulou, Theoni Leonidopoulou, Vasileios Xanthopoulos, Stamatios Karakatsanis, Effimia Vrakidou, Sophia Chatziioannou, Dimitrios Drougkas, Eleftheria Hatzimichael, Gabriella Gainaru, Maria Palassopoulou, Maria Tsirogianni, Maria Kotsopoulou, Gerassimos Tsourouflis, Evangelia Skoura, Catherine Mainta, Evangelos Terpos, Christos Poziopoulos, Theodora Triantafyllou, Panayiotis Zikos, Argyro Koumarianou, Dimitra Liapi, Vassiliki Pappa, Evgenia Verrou, Panayiotis Tsirigotis, Vassiliki Labropoulou, Helen Papadaki, Ioannis Datseris, Argiris Symeonidis, Maria Bouzani, Maria Bakiri, Themis Karmiris, Maria K Angelopoulou, Phivi Rondogianni
Publication date
2023/11
Journal
HemaSphere
Volume
7
Issue
11
Pages
e965
Publisher
Lippincott Williams & Wilkins
Description
Anthracycline-based chemoimmunotherapy (CIT) has improved the outcomes in primary mediastinal large B-cell lymphoma (PMLBCL). 1–3 Current research focuses on minimizing radiotherapy (RT) use by positron emission tomography/computed tomography (PET/CT)-adapted decisions, intensification of CIT, or both. 4–7 The National Cancer Institute (NCI) introduced the intensified rituximab and dose-adjusted etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin (R-da-EPOCH) regimen, which produced better results than historically achieved with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), while minimizing consolidative RT. 7–9
At the end-of-treatment (EoT), residual masses are very common. Positron emission tomography/computed tomography (PET/CT) is required to address their clinical significance. Following R-CHOP, even patients with Deauville 5 …
Total citations
20242
Scholar articles
TP Vassilakopoulos, A Piperidou, Z Mellios, E Verigou… - HemaSphere, 2023